The chemical composition of the cervical mucus (CM), its physical characteristics and the volume of secretion change cyclically throughout the menstrual cycle. The aim of this study was to identify the constitutive protein composition of CM of fertile women and the changes in the CM proteome throughout the menstrual cycle. Five fertile women who had a term delivery within 1 year before the study were enrolled. Proteomic analysis was performed using an Ultimate 3000 Nano/Micro-HPLC apparatus equipped with an FLM-3000-Flow manager module and coupled with an LTQ Orbitrap XL hybrid mass spectrometer; bioinformatic software was used for functional and quantitative analysis. 59, 81 and 43 proteins (mean) were respectively identified in the pre-ov...
Follicular fluid (FF) acts as a vehicle for paracrine signalling between somatic cells of the follic...
Abstract PURPOSE: In the frame of a research study on possible urinary markers related to physiologi...
Additional file 1: Table S1. Identified proteins in CM in the group of controls and in patients affe...
The chemical composition of the cervical mucus (CM), its physical characteristics and the volume of ...
Cervical mucus (CM) is a viscous fluid that is produced by the cervical glands and functions as a ut...
The female genital tract includes several anatomical regions whose luminal fluids successively inter...
ObjectiveTo understand glycosylation of endocervical proteins at different times throughout the mens...
Inherent interindividual and intraindividual variation in the length of the menstrual cycle limits t...
Proteases irreversibly modify proteins by hydrolyzing the bonds between amino acids and are implicat...
The pathophysiology of vaginal conditions is still ill-defined at a molecular level. Because the pro...
The molecular mechanisms involved in human uterine quiescence during gestation and the induction of ...
Abstract Cervicovaginal fluid has an important function in the homeostasis and immunity of the lower...
Objectives: To identify those proteins differentially expressed in the uterine cavity according to c...
Aim: Cervico-vaginal fluid (CVF) may provide insight into the biochemical pathways of human reproduc...
Although essential for artificial insemination (AI) and MOET (multiple ovulation and embryo transfer...
Follicular fluid (FF) acts as a vehicle for paracrine signalling between somatic cells of the follic...
Abstract PURPOSE: In the frame of a research study on possible urinary markers related to physiologi...
Additional file 1: Table S1. Identified proteins in CM in the group of controls and in patients affe...
The chemical composition of the cervical mucus (CM), its physical characteristics and the volume of ...
Cervical mucus (CM) is a viscous fluid that is produced by the cervical glands and functions as a ut...
The female genital tract includes several anatomical regions whose luminal fluids successively inter...
ObjectiveTo understand glycosylation of endocervical proteins at different times throughout the mens...
Inherent interindividual and intraindividual variation in the length of the menstrual cycle limits t...
Proteases irreversibly modify proteins by hydrolyzing the bonds between amino acids and are implicat...
The pathophysiology of vaginal conditions is still ill-defined at a molecular level. Because the pro...
The molecular mechanisms involved in human uterine quiescence during gestation and the induction of ...
Abstract Cervicovaginal fluid has an important function in the homeostasis and immunity of the lower...
Objectives: To identify those proteins differentially expressed in the uterine cavity according to c...
Aim: Cervico-vaginal fluid (CVF) may provide insight into the biochemical pathways of human reproduc...
Although essential for artificial insemination (AI) and MOET (multiple ovulation and embryo transfer...
Follicular fluid (FF) acts as a vehicle for paracrine signalling between somatic cells of the follic...
Abstract PURPOSE: In the frame of a research study on possible urinary markers related to physiologi...
Additional file 1: Table S1. Identified proteins in CM in the group of controls and in patients affe...